These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33019603)

  • 1. RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin.
    Machado-Lima A; López-Díez R; Iborra RT; Pinto RS; Daffu G; Shen X; Nakandakare ER; Machado UF; Corrêa-Giannella MLC; Schmidt AM; Passarelli M
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In type 2 diabetes mellitus glycated albumin alters macrophage gene expression impairing ABCA1-mediated cholesterol efflux.
    Machado-Lima A; Iborra RT; Pinto RS; Castilho G; Sartori CH; Oliveira ER; Okuda LS; Nakandakare ER; Giannella-Neto D; Machado UF; Corrêa-Giannella ML; Traldi P; Porcu S; Roverso M; Lapolla A; Passarelli M
    J Cell Physiol; 2015 Jun; 230(6):1250-7. PubMed ID: 25413254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes.
    Daffu G; Shen X; Senatus L; Thiagarajan D; Abedini A; Hurtado Del Pozo C; Rosario R; Song F; Friedman RA; Ramasamy R; Schmidt AM
    Diabetes; 2015 Dec; 64(12):4046-60. PubMed ID: 26253613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin Blocks Advanced Glycation End Products Induced Reduction in Macrophage Cholesterol Efflux Mediated With ATP-Binding Cassette Transporters G 1.
    Xu L; Wang YR; Li PC; Feng B
    Circ J; 2019 Aug; 83(9):1954-1964. PubMed ID: 31378770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin blocks advanced glycation end products-elicited reduction of macrophage cholesterol efflux by suppressing NADPH oxidase activity via inhibition of geranylgeranylation of Rac-1.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Horm Metab Res; 2011 Aug; 43(9):619-24. PubMed ID: 21823057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 22016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis and Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage.
    Schmidt AM
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):613-621. PubMed ID: 28183700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA-1-mediated reverse cholesterol transport.
    Machado-Lima A; Iborra RT; Pinto RS; Sartori CH; Oliveira ER; Nakandakare ER; Stefano JT; Giannella-Neto D; Corrêa-Giannella ML; Passarelli M
    Diabetes Metab Res Rev; 2013 Jan; 29(1):66-76. PubMed ID: 23015358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability.
    Zhou X; Weng J; Xu J; Xu Q; Wang W; Zhang W; Huang Q; Guo X
    Cell Physiol Biochem; 2018; 45(4):1717-1730. PubMed ID: 29490301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Effect of Advanced Glycated Albumin Driving Inflammation and Disturbances in Cholesterol Efflux in Macrophages.
    Minanni CA; Machado-Lima A; Iborra RT; Okuda LS; de Souza Pinto R; Santana MFM; Lira ALA; Nakandakare ER; Côrrea-Giannella MLC; Passarelli M
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684632
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    López-Díez R; Shen X; Daffu G; Khursheed M; Hu J; Song F; Rosario R; Xu Y; Li Q; Xi X; Zou YS; Li H; Schmidt AM; Yan SF
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1536-1547. PubMed ID: 28642238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism.
    Senatus L; López-Díez R; Egaña-Gorroño L; Liu J; Hu J; Daffu G; Li Q; Rahman K; Vengrenyuk Y; Barrett TJ; Dewan MZ; Guo L; Fuller D; Finn AV; Virmani R; Li H; Friedman RA; Fisher EA; Ramasamy R; Schmidt AM
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products decrease collagen I levels in fibroblasts from the vaginal wall of patients with POP via the RAGE, MAPK and NF-κB pathways.
    Chen YS; Wang XJ; Feng W; Hua KQ
    Int J Mol Med; 2017 Oct; 40(4):987-998. PubMed ID: 28849117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integral role of receptor for advanced glycation end products (RAGE) in nondiabetic atherosclerosis.
    Uekita H; Ishibashi T; Shiomi M; Koyama H; Ohtsuka S; Yamamoto H; Yamagishi S; Inoue H; Itabe H; Sugimoto K; Kamioka M; Ohkawara H; Wada I; Yasuchika T
    Fukushima J Med Sci; 2019; 65(3):109-121. PubMed ID: 31915324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
    Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.
    Santos-Bezerra DP; Machado-Lima A; Monteiro MB; Admoni SN; Perez RV; Machado CG; Shimizu MH; Cavaleiro AM; Thieme K; Queiroz MS; Machado UF; Giannella-Neto D; Passarelli M; Corrêa-Giannella ML
    Diab Vasc Dis Res; 2018 Jan; 15(1):81-89. PubMed ID: 29027826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products.
    Liebisch M; Bondeva T; Franke S; Hause S; Wolf G
    Nephrol Dial Transplant; 2017 Apr; 32(4):641-653. PubMed ID: 27638909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes.
    Phimphilai M; Pothacharoen P; Kongtawelert P
    Front Endocrinol (Lausanne); 2021; 12():726182. PubMed ID: 34512554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycated albumin impairs HDL anti-inflammatory activity and primes macrophages for inflammatory response that reduces reverse cholesterol transport.
    Okuda LS; Castilho G; Rocco DD; Nakandakare ER; Catanozi S; Passarelli M
    Biochim Biophys Acta; 2012 Dec; 1821(12):1485-92. PubMed ID: 22940078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages.
    Brown BE; Nobecourt E; Zeng J; Jenkins AJ; Rye KA; Davies MJ
    PLoS One; 2013; 8(5):e65430. PubMed ID: 23741493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-22 is induced by S100/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1.
    Chellan B; Yan L; Sontag TJ; Reardon CA; Hofmann Bowman MA
    J Lipid Res; 2014 Mar; 55(3):443-54. PubMed ID: 24367046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.